Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Cytokine ; 175: 156484, 2024 03.
Artigo em Inglês | MEDLINE | ID: mdl-38159471

RESUMO

The anti-inflammatory role of physical exercise is mediated by interleukin 10 (IL-10), and their release is possibly upregulated in response to IL-6. Previous studies demonstrated that mice lacking IL-6 (IL-6 KO mice) exhibited diminished exercise tolerance, and reduced strength. Rev-erbα, a transcriptional suppressor involved in circadian rhythm, has been discovered to inhibit the expression of genes linked to bodily functions, encompassing inflammation and metabolism. It also plays a significant role in skeletal muscle and exercise performance capacity. Given the potential association between Rev-erbα and the immune system and the fact that both pathways are modulated following acute aerobic exercise, we examined the physical performance of IL-10 KO mice and analyzed the modulation of the atrophy and Rev-erbα pathways in the muscle of wild type (WT) and IL-10 KO mice following one session of acute exercise. For each phenotype, WT and IL-10 KO were divided into two subgroups (Control and Exercise). The acute exercise session started at 6 m/min, followed by 3 m/min increments every 3 min until animal exhaustion. Two hours after the end of the exercise protocol, the gastrocnemius muscle was removed and prepared for the reverse transcription-quantitative polymerase chain reaction (RT-q-PCR) and immunoblotting technique. In summary, compared to WT, the IL-10 KO animals showed lower body weight and grip strength in the baseline. The IL-10 control group presented a lower protein content of BMAL1. After the exercise protocol, the IL-10 KO group had higher mRNA levels of Trim63 (atrophy signaling pathway) and lower mRNA levels of Clock and Bmal1 (Rev-erbα signaling pathway). This is the first study showing the relationship between Rev-erbα and atrophy in IL-10 KO mice. Also, we accessed a public database that analyzed the gastrocnemius of MuRF KO mice submitted to two processes of muscle atrophy, a denervation surgery and dexamethasone (Dexa) injections. Independently of knockout, the denervation demonstrated lower Nr1d1 levels. In conclusion, IL-10 seems to be a determinant in the Rev-erbα pathway and atrophy after acute exercise, with no modulation in the baseline state.


Assuntos
Fatores de Transcrição ARNTL , Interleucina-10 , Animais , Camundongos , Fatores de Transcrição ARNTL/genética , Fatores de Transcrição ARNTL/metabolismo , Atrofia , Interleucina-10/genética , Interleucina-6/genética , Camundongos Knockout , Proteínas Musculares/genética , Músculo Esquelético/metabolismo , RNA Mensageiro/metabolismo , Proteínas com Motivo Tripartido , Ubiquitina-Proteína Ligases
2.
Life (Basel) ; 13(10)2023 Sep 28.
Artigo em Inglês | MEDLINE | ID: mdl-37895359

RESUMO

Colorectal cancer (CRC) is one of the most common causes of death and the third most diagnosed cancer worldwide. The tumor microenvironment and cancer stem cells participate in colorectal tumor progression and can dictate malignancy. Nutrition status affects treatment response and the progression or recurrence of the tumor. This review summarizes the main bioactive compounds against the molecular pathways related to colorectal carcinogenesis. Moreover, we focus on the compounds with chemopreventive properties, mainly polyphenols and carotenoids, which are highly studied dietary bioactive compounds present in major types of food, like vegetables, fruits, and seeds. Their proprieties are antioxidant and gut microbiota modulation, important in the intestine because they decrease reactive oxygen species and inflammation, both principal causes of cancer. These compounds can promote apoptosis and inhibit cell growth, proliferation, and migration. Combined with oncologic treatment, a sensitization to first-line colorectal chemotherapy schemes, such as FOLFOX and FOLFIRI, is observed, making them an attractive and natural support in the oncologic treatment of CRC.

3.
Clin Transl Oncol ; 25(12): 3357-3368, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37610496

RESUMO

We aim to provide an overview of the research available on indoor radon and lung cancer, with a special focus on Spanish investigations. Early studies on underground miners established the link between radon and lung cancer, which was later confirmed for the general population by residential case-control studies. Spain contributed with extensive evidence, including 5 multicentric, hospital-based, case-control studies in the last 30 years, exploring diverse aspects, such as radon's effect on never-smokers, molecular pathways linking radon exposure to lung cancer risk, survival rates, mortality burden, and occupational exposure. There is a well-established causal association between radon with lung cancer. Despite pioneering research performed in our country by the Galician Radon Laboratory, particularly on driver genes, the evidence on the potential molecular pathways which makes radon a carcinogen is sparse. Also, relevant questions on the potential association of radon exposure with the induction of other diseases are still pending.


Assuntos
Poluição do Ar em Ambientes Fechados , Neoplasias Pulmonares , Neoplasias Induzidas por Radiação , Radônio , Humanos , Radônio/efeitos adversos , Radônio/análise , Neoplasias Pulmonares/epidemiologia , Neoplasias Pulmonares/etiologia , Poluição do Ar em Ambientes Fechados/efeitos adversos , Neoplasias Induzidas por Radiação/etiologia , Risco
4.
Int J Mol Sci ; 24(6)2023 Mar 17.
Artigo em Inglês | MEDLINE | ID: mdl-36982866

RESUMO

Parkinson's disease is a neurodegenerative disease whose progression and clinical characteristics have a close bidirectional and multilevel relationship with the process of neuroinflammation. In this context, it is necessary to understand the mechanisms involved in this neuroinflammation-PD link. This systematic search was, hereby, conducted with a focus on the four levels where alterations associated with neuroinflammation in PD have been described (genetic, cellular, histopathological and clinical-behavioral) by consulting the PubMed, Google Scholar, Scielo and Redalyc search engines, including clinical studies, review articles, book chapters and case studies. Initially, 585,772 articles were included, and, after applying the inclusion and exclusion criteria, 84 articles were obtained that contained information about the multilevel association of neuroinflammation with alterations in gene, molecular, cellular, tissue and neuroanatomical expression as well as clinical-behavioral manifestations in PD.


Assuntos
Doenças Neurodegenerativas , Doença de Parkinson , Humanos , Doença de Parkinson/genética , Doenças Neurodegenerativas/genética , Doenças Neuroinflamatórias
5.
Arch Gerontol Geriatr ; 106: 104870, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-36442406

RESUMO

BACKGROUND: Frailty and ST-Elevation Myocardial Infarction (STEMI) share similar molecular pathways. Specific biomarkers, such as microRNAs (miRNAs), may provide insights into the molecular mechanisms that cause the relationship between frailty and STEMI. OBJECTIVE: Our aim was to identify and compare circulating miRNA levels between frail and non-frail older adults following STEMI and comprehend the regulatory miRNA-gene networks and pathways involved in this condition. METHODS: This exploratory study is a subanalysis of a larger observational study. In this study, we selected patients ≥ 65 years old, following STEMI, with pre-frail/frail (n=5) and non-frail (n=4) phenotype evaluated using the Clinical Frailty Scale and serum circulating miRNA levels were analyzed. RESULTS: Pre-frail/frail patients had greater serum levels of 53 miRNAs, compared with non-frail patients. Notably, miR-103a-3p, miR-598-3p, and miR-130a-3p were the top three significantly deregulated miRNAs predicted to modulate gene expression associated with aging. Additional computational analyses showed 7,420 predicted miRNA gene targets, which were regulated by at least two of the 53 identified miRNAs. Pathway enrichment analysis showed that axon guidance and MAPK signaling were among pathways regulated by miRNA target genes. CONCLUSIONS: These novel findings suggest a correlation between the identified miRNAs, target genes, and pathways in pre-frail and frail patients with myocardial infarction.


Assuntos
MicroRNA Circulante , Fragilidade , Infarto do Miocárdio com Supradesnível do Segmento ST , Humanos , MicroRNA Circulante/sangue , MicroRNA Circulante/metabolismo , Fragilidade/sangue , Fragilidade/diagnóstico , Fragilidade/metabolismo , Infarto do Miocárdio com Supradesnível do Segmento ST/sangue , Infarto do Miocárdio com Supradesnível do Segmento ST/diagnóstico , Infarto do Miocárdio com Supradesnível do Segmento ST/metabolismo , Redes e Vias Metabólicas
6.
Curr Issues Mol Biol ; 44(8): 3770-3778, 2022 Aug 20.
Artigo em Inglês | MEDLINE | ID: mdl-36005154

RESUMO

Colorectal cancer is a heterogeneous disease with multiple genomic changes that influence the clinical management of patients; thus, the search for new molecular targets remains necessary. The aim of this study was to identify genetic variants in tumor tissues from Mexican patients with colorectal cancer, using massive parallel sequencing. A total of 4813 genes were analyzed in tumoral DNA from colorectal cancer patients, using the TruSight One Sequencing panel. From these, 192 variants with clinical associations were found distributed in 168 different genes, of which 46 variants had not been previous reported in the literature or databases, although genes harboring those variants had already been described in colorectal cancer. Enrichment analysis of the affected genes was performed using Reactome software; pathway over-representation showed significance for disease, signal transduction, and immune system subsets in all patients, while exclusive subsets such as DNA repair, autophagy, and RNA metabolism were also found. Those characteristics, whether individual or shared, could give tumors specific capabilities for survival, aggressiveness, or response to treatment. Our results can be useful for future investigations targeting specific characteristics of tumors in colorectal cancer patients. The identification of exclusive or common pathways in colorectal cancer patients could be important for better diagnosis and personalized cancer treatment.

8.
Photodiagnosis Photodyn Ther ; 35: 102292, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-33857598

RESUMO

The study evaluated the effect of antimicrobial photodynamic therapy (aPDT) and nystatin (NYS) in the expression of genes (ACT1, ALS1, CAP1, CAT1, EFG1, HWP1, LIP3, PLB1, SAP1, and SOD1) involved in the virulence of Candida albicans strains recovered from patients with denture stomatitis (DS). These strains were isolated from the patients before (initial) and after treatment (final), and 45 days after the treatments (follow-up). For gene expression analyses, RNA was isolated from the clinical strains, followed by cDNA synthesis and qPCR using specific primers for each target gene. The samples that present integrity were pooled to increase the RNA yield. In the end, four patients treated with aPDT and five patients treated with NYS had the clinical isolates of C. albicans submitted to gene expression evaluation. The data demonstrated a statistical difference in the expression of PLB1 and ACT1 for the different therapies (aPDT versus NYS). Also, there was a statistical difference in the expression of CAT1, SOD1, and LIP3 at the time intervals assessed (initial, final, and follow-up). In contrast, no statistical difference was found in the expression of ALS1, HWP1, EFG1, CAP1, CAT1, SOD1, LIP3, and SAP1 between the therapies, while no significant difference was detected at the time intervals evaluated for ALS1, HWP1, EFG1, CAP1, and SAP1. Therefore, the topical treatments for DS with aPDT or NYS did not effect the expression of most C. albicans virulence genes evaluated.


Assuntos
Fotoquimioterapia , Estomatite sob Prótese , Candida albicans/genética , Expressão Gênica , Humanos , Nistatina/uso terapêutico , Fotoquimioterapia/métodos , Fármacos Fotossensibilizantes/uso terapêutico , Estomatite sob Prótese/tratamento farmacológico
9.
Front Nutr ; 8: 775515, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-35004810

RESUMO

Introduction: Tobacco smoke is associated with oxidative and inflammatory pathways, increasing the risk of chronic-degenerative diseases. Our goal was to evaluate the effects of acute "Pera" and "Moro" orange juice consumption on inflammatory processes and oxidative stress in microRNA (miRNA) expression in plasma from healthy smokers. Methods: This was a randomized crossover study that included healthy smokers over 18 years old. Blood samples were collected before and 11 h after beverage ingestion. Participants were instructed to drink 400 mL of Pera orange juice (Citrus sinensis), Moro orange juice (Citrus sinensis L. Osbeck), or water. Each subject drank the beverages in a 3-way crossover study design. Inflammatory and oxidative stress biomarkers and circulating miRNA expression profiles were determined. The subjects maintained their usual tobacco exposure during the experiment. Results: We included 18 individuals (12 men and 6 women), with 37.0 ± 12.0 years old. All subjects received the 3 interventions. Increased expression of circulating miRNAs (miR-150-5p, miR-25-3p, and miR-451a) was verified after cigarette smoking, which were attenuated after intake of both types of orange juice. There was no difference regarding serum levels of TNF-α, IL-6, MMP-9, and C-reactive protein. Despite the increased activity of serum superoxide dismutase and glutathione peroxidase after "Pera" or "Moro" orange juice intake, respectively, no changes in lipid hydroperoxide levels were detected. Conclusion: Tobaccos smokers showed increased expression of miR-150-5p, miR-25-3p, and miR-451a was noted, and attenuated by orange juice intake. miRNAs were predicted to regulate 244 target genes with roles in oxidative stress, PI3K-Akt, and MAPK signaling, which are pathways frequently involved in smoking-related cardiovascular diseases and cancer.

10.
Curr Protein Pept Sci ; 22(1): 19-28, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33292152

RESUMO

Human interferon-stimulated gene 15 (ISG15) is a 15-kDa ubiquitin-like protein that can be detected as either free ISG15 or covalently associated with its target proteins through a process termed ISGylation. Interestingly, extracellular free ISG15 has been proposed as a cytokinelike protein, whereas ISGylation is a posttranslational modification. ISG15 is a small protein with implications in some biological processes and pathologies that include cancer. This review highlights the findings of both free ISG15 and protein ISGylation involved in several molecular pathways, emerging as central elements in some cancer types.


Assuntos
Citocinas/genética , Peptídeos e Proteínas de Sinalização Intracelular/genética , Neoplasias/genética , Processamento de Proteína Pós-Traducional , Ubiquitina Tiolesterase/genética , Enzimas de Conjugação de Ubiquitina/genética , Ubiquitinas/genética , Citocinas/química , Citocinas/imunologia , Regulação Neoplásica da Expressão Gênica , Humanos , Imunidade Inata , Interferon-alfa/genética , Interferon-alfa/imunologia , Interferon beta/genética , Interferon beta/imunologia , Peptídeos e Proteínas de Sinalização Intracelular/imunologia , Modelos Moleculares , Neoplasias/imunologia , Neoplasias/patologia , Conformação Proteica em alfa-Hélice , Conformação Proteica em Folha beta , Domínios e Motivos de Interação entre Proteínas , Transdução de Sinais , Ubiquitina Tiolesterase/imunologia , Enzimas de Conjugação de Ubiquitina/imunologia , Ubiquitinação , Ubiquitinas/química , Ubiquitinas/imunologia
12.
Gastroenterol. latinoam ; 27(2): 106-113, 2016. tab
Artigo em Espanhol | LILACS | ID: biblio-907622

RESUMO

Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide. Most cases occur in patients with chronic liver disease who are diagnosed at an advanced stage, and their prognosis is poor. Because HCC is resistant to conventional systemic therapies, molecular therapies have emerged and been established as the standard for advanced forms of the disease. Since the publication of phase III clinical studies on sorafenib, research has searched for new molecular targets. Thus, multiple clinical studies that inhibit relevant molecular pathways have been performed with numerous patients. Many of these trials have had unexpectedly negative results, not only due to patient complexity and the difficulty in evaluating a therapeutic response, quality of life and the survival rate but also because phase II clinical studies, without the selection of molecular targets, have continued on to poor results in phase III studies. This review article aims to evaluate different phase II and phase III clinical studies to understand the clinically relevant molecular pathways and to improve the future management of HCC patients.


El carcinoma hepatocelular (CHC) es uno de los tumores más comunes a nivel mundial. La mayoría de los casos ocurre en pacientes con enfermedad hepática crónica, quienes son diagnosticados en un estado avanzado con muy pobre pronóstico. Terapias moleculares orientadas al tratamiento del CHC han sido destacadas; estas pueden afectar la proliferación celular del tumor, diferenciación celular, angiogénesis, invasión y metástasis, entre otros procesos críticos al desarrollo del tumor. El estándar para el CHC avanzado es la terapia target usando Sorafenib, sin embargo, nuevas moléculas han sido testeadas en estudios fase III de primera línea, tales como sunitinib, brivanib, erlotinib y linifanib, sin superioridad sobre sorafenib. La investigación de nuevos tratamientos es un desafío para investigadores, hepatólogos y oncólogos. Las principales vías moleculares de CHC con relevancia en estudios clínicos fase II y III son: MAP-kinase (MAPK), PI3K/AKT/mTOR, (HGF)/c-Met, cromatina y regulación epigenética, mantenimiento de telómeros, Notch, Hedgehog, Hippo y vía señalizante Jak/STAT. Las terapias futuras en CHC pueden ser orientadas rutinariamente usando sólo objetivos adecuados para terapias moleculares y seleccionando subgrupos de pacientes sobre la base de la expresión de targets moleculares o basados en nuevas clasificaciones definidas por estudios genómicos.


Assuntos
Humanos , Carcinoma Hepatocelular/tratamento farmacológico , Neoplasias Hepáticas/tratamento farmacológico , Compostos de Fenilureia/uso terapêutico , Inibidores de Proteínas Quinases/uso terapêutico , Progressão da Doença , Niacinamida/análogos & derivados , Análise de Sobrevida
13.
Rev. bras. ciênc. mov ; 17(3): 104-113, jan.-mar. 2009. ilus
Artigo em Português | LILACS | ID: lil-727847

RESUMO

O objetivo deste estudo foi elaborar uma revisão dos principais mecanismos celulares e moleculares envolvidos no processo de hipertrofia e modulação fenotípica do músculo esquelético, em resposta ao exercício/treinamento físico. Inicialmente, apresentamos uma visão geral do músculo esquelético, com ênfase nas características gerais das fibras musculares e na plasticidade muscular. Em seguida, descrevemos a morfologia e a participação dos mionúcleos e das células satélites durante a hipertrofia muscular, e também, a atuação dos fatores de crescimento sobre a atividade das células satélites. Finalmente, apontamos as principais vias moleculares que mediam as alterações na expressão de proteínas músculo-específicas, de acordo com a especificidade das respostas funcionais ao exercício/treinamento físico.


The aim of this study was prepare a review of the majors cellular and molecular mechanisms involved in hypertrophy and phenotypic modulation of skeletal muscle in response to exercise/physical training. Initially, we present an overview of skeletal muscle, with emphasis on the general characteristics of the muscle fibers and muscle plasticity. Then, we describe the morphology and participation of myonuclei and satellite cells during muscle hypertrophy, and also the action of growth factors on the activity of cells satellites. Finally, we showed the key molecular pathways that mediate changes in the expression of muscle-specific proteins, according to the specificity of functional responses to the exercise/physical training.


Assuntos
Humanos , Células , Exercício Físico , Hipertrofia , Músculo Esquelético , DNA Satélite , Atividade Motora , RNA Satélite
14.
Rev. venez. endocrinol. metab ; 3(3): 20-29, oct. 2005. ilus, graf, tab
Artigo em Espanhol | LILACS-Express | LILACS | ID: lil-631312

RESUMO

La obesidad es un área multidisciplinaria, cuya biología abarca: 1) los mecanismos fundamentales sobre la regulación del balance energético; 2) las bases genómicas para el desarrollo de la obesidad, 3) las vías celulares de las funciones del tejido adiposo; 4) la descripción molecular del estado obeso; 5) las consecuencias patológicas de la obesidad; 6) las bases fisiológicas para las estrategias de tratamiento. El tejido adiposo es reconocido hoy en día como un órgano endocrino clave, cuya comunicación amplia es efectuada tanto con el cerebro como con tejidos periféricos a través de estas adipocinas. La obesidad es caracterizada por una inflamación moderada y el adipocito parece ser el sitio principal de este estado inflamatorio, que lo estimula a producir citocinas, quimiocinas, proteínas de fase aguda, y factores angiogénicos. En este artículo, discutiremos las vías de señalizaciones celulares y moleculares que se encuentran en las intersecciones de los caminos inflamatorios y metabólicos que contribuyen al desarrollo de la diabetes y la disfunción endotelial a través de un exceso de grasa corporal. También nos atrevemos a sugerir varios modelos que pretenden explicar la integración de las vías inflamatorias y metabólicas dentro del contexto de las enfermedades del metabolismo y la obesidad.


Obesity is a multidisciplinary topic, the biology of which includes: 1) the f fundamental mechanisms of energy balance and its regulation; 2) the genomic basis for the development of obesity; 3) the cellular pathways of adipose tissue function; 4) the molecular description of the obese state; 5) the pathological consequences of obesity; 6) the physiological basis for treatment strategies. Adipose tissue is now recognized as a key endocrine organ, communicating both with the brain and peripheral tissues through the adipokines. Obesity is characterized by mild inflammation, and the adipocyte may be the main locus of the inflammatory state, producing cytokines, chemokines, acute-phase proteins and angiogenic factors. In this article, we discuss the molecular and cellular signaling pathways at the intersection of metabolism and inflammation that contribute to diabetes and endothelial dysfunction through an excess of body fat. We dare to suggest several models for the integration of inflammatory and metabolic pathways in metabolic disease and obesity.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA